Literature DB >> 17560140

Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.

Silvio Diego Bianchi1, Matteo Scoletta, Francesca Bozzalla Cassione, Giuseppe Migliaretti, Marco Mozzati.   

Abstract

OBJECTIVES: To study bisphosphonate-associated osteonecrosis of the jaw with respect to radiographic, demographic, and clinical features. STUDY
DESIGN: Thirty-two patients with painful exposed bone in the jaws subsequent to treatment with bisphosphonates for various neoplastic diseases were examined with both dental panoramic radiograph and multislice spiral computerized tomography (CT). Each case was assessed for the following radiologic signs: structural alteration of trabecular bone, cortical bone erosion, osteosclerosis, small sequestrum, extensive sequestrum, and presence of periosteal new bone. The McNemar, chi2, and Kruskall-Wallis tests were performed to analyze the association between radiologic signs, demographic data, clinical aspects of the lesion, and type and duration of bisphosphonate therapy. Hierarchical cluster analysis was used to group patients into categories on the basis of CT signs and dental panoramic radiograph signs. The agreement between CT and dental panoramic radiograph clusters was analyzed by kappa index.
RESULTS: Dental panoramic radiograph proved positive for features of osteonecrosis in 18 cases and CT in 30. Computerized tomography was far superior to dental panoramic radiograph in detecting all the radiologic signs. The cluster analysis applied to CT signs showed a classification of the 32 patients in 4 categories characterized by an increasing number of signs coherent with the clinical extension of the lesions. Structural alteration of trabecular bone and cortical bone erosion, a constant finding in the 30 positive CTs, could be sometimes differentiated only with difficulty from those due to recent extraction. Dental panoramic radiograph missed the correct diagnosis of sequestration in 15 cases. Intense periosteal reaction was often found. The most extensive maxillary lesions were associated with new bone formation in Schneider mucous membrane, never described previously, and oroantral communications.
CONCLUSIONS: Dental panoramic radiograph were found to be of limited use in assessing bisphosphonate-associated osteonecrosis of the jaw in patients for whom CT imaging was subsequently ordered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560140     DOI: 10.1016/j.tripleo.2007.01.040

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  32 in total

Review 1.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

2.  Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis.

Authors:  S R Torres; C S K Chen; B G Leroux; P P Lee; L G Hollender; M M Schubert
Journal:  Dentomaxillofac Radiol       Date:  2011-12       Impact factor: 2.419

3.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

Review 4.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

5.  Prevalence of radiographic findings on jaws exposed to antiresorptive therapy: a meta-analysis.

Authors:  Kamile Leonardi Dutra; Letícia Fernanda Haas; Glaucia S Zimmermann; Gilberto Melo; Mariana Comparotto Minamisako; Carlos Flores-Mir; Márcio Corrêa
Journal:  Dentomaxillofac Radiol       Date:  2018-11-07       Impact factor: 2.419

Review 6.  Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies.

Authors:  Vassilios Vassiliou; Nikolaos Tselis; Dimitrios Kardamakis
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

7.  Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Authors:  Ben Kang; Simon Cheong; Thawinee Chaichanasakul; Olga Bezouglaia; Elisa Atti; Sarah M Dry; Flavia Q Pirih; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

8.  Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation.

Authors:  Sharon Elad; Moshe J Gomori; Noa Ben-Ami; Silvina Friedlander-Barenboim; Eran Regev; Towy S Lazarovici; Noam Yarom
Journal:  Clin Oral Investig       Date:  2009-07-15       Impact factor: 3.573

9.  Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.

Authors:  Philipp Stockmann; Fabian M Hinkmann; Michael M Lell; Matthias Fenner; Eleftherios Vairaktaris; Friedrich-Wilhelm Neukam; Emeka Nkenke
Journal:  Clin Oral Investig       Date:  2009-06-10       Impact factor: 3.573

10.  Image findings of bisphosphonate related osteonecrosis of jaws comparing with osteoradionecrosis.

Authors:  Kenichi Obinata; Shinichi Shirai; Hitoshi Ito; Motoyasu Nakamura; Marco Carrozzo; Iain Macleod; Andrew Carr; Yutaka Yamazaki; Kanchu Tei
Journal:  Dentomaxillofac Radiol       Date:  2017-03-16       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.